Shanghai (P.R.China) October 23, 2014 – Luqa Pharmaceuticals today announced its attendance to the China Forum 2014. The conference will be held in Frankfurt, Germany on November 2, 2014 and will precede EBD Group’s international partnering conference, BIO-Europe® 2014.
Now in its fifth year, China Forum 2014 will be a full-day event, bringing together China-based life science executives with their counterparts from Europe and the rest of the world. The event will provide insights into recent developments of the rapidly changing life science industry in China.
Executives from China and the West will discuss partnering opportunities and attendees will gain essential knowledge on how to step into new marketplaces. In an interactive setting, attendees from Western countries will hear what it takes to succeed in China, and Chinese executives will learn how to leverage their business by partnering with European and American companies.
The conference will feature a number of panels covering China-related topics. Luqa’s CEO, Robert Braithwaite will participate on the panel “Business Development across Borders” on November 2, 2014 at 16:15. The panel will be moderated by Li Wang, Director of Academic Alliances at AstraZeneca and will also include Mike Liu, PhD (Henrui); Jimmy Wei, PhD (KPCB); and Tony Li, PhD, MBA (Baheal Pharmaceutical Group).
Please visit www.ebdgroup.com/bioeurope/cf/ for more information.
Luqa Pharmaceuticals is a China-focused company. We acquire, develop and commercialize innovative healthcare products that bring added value to prescribers and other healthcare providers while enhancing quality of life for patients. Since its inception in 2010, Luqa has become a fast-growing revenue generating company with a broad product portfolio and pipeline. We aim to become a leader in specialty care segments in China. Please visit us at www.luqapharma.com.